Skip to main content
SpringerLink
Log in

Infection, Skin, and Systemic Malignancy

  • Chapter
  • First Online:
Dermato-Oncology Study Guide

  • 327 Accesses

Abstract

The interplay between infection and systemic malignancy can impact quality-of-life and likelihood of survival. The dynamic relationship between infection and systemic malignancy is highlighted by a broad spectrum of pathology: (1) Cutaneous infections related to the malignancy itself, its treatment (chemotherapy and/or radiation), or invasive procedures used for diagnosis or treatment; (2) Cutaneous infections related to specific therapies for malignancy; and (3) Infections which predispose to cutaneous malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CMV:

Cytomegalovirus

DLBCL:

Diffuse large B-cell lymphoma

EBV:

Epstein-Barr virus

EGFR:

Epidermal growth factor receptor

HHV8:

Human herpes virus 8

HPV:

Human papillomavirus

HSV:

Herpes simplex virus

I&D:

Incision and drainage

MCC:

Merkel cell carcinoma

NKTL:

Natural killer/T-cell lymphoma]

PTLD:

Post-transplant lymphoproliferative disease

RZV:

Recombinant glycoprotein E vaccine

SCC:

Squamous cell carcinoma

SSTI:

Skin and soft tissue infections

Tx:

Treatment

VZV:

Varicella zoster virus

ZVL:

Zoster vaccine live

References

  1. Kofteridis DP, Valachis A, Koutsounaki E, Maraki S, Mavrogeni E, Economidou FN, et al. Skin and soft tissue infections in patients with solid tumours. Sci World J. 2012;2012:804518.

    Article  Google Scholar 

  2. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427–31.

    Article  Google Scholar 

  3. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):147–59.

    Article  Google Scholar 

  4. Grunwald MR, McDonnell MH, Induru R, Gerber JM. Cutaneous manifestations in leukemia patients. Semin Oncol. 2016;43(3):359–65.

    Article  Google Scholar 

  5. Vaiman M, Lazarovitch T, Heller L, Lotan G. Ecthyma gangrenosum and ecthyma-like lesions: review article. Eur J Clin Microbiol Infect Dis. 2015;34(4):633–9.

    Article  CAS  Google Scholar 

  6. Lai CC, Tan CK, Cheng A, Chung KP, Chen CY, Liao CH, et al. Nontuberculous mycobacterial infections in cancer patients in a medical center in Taiwan, 2005-2008. Diagn Microbiol Infect Dis. 2012;72(2):161–5.

    Article  Google Scholar 

  7. Henkle E, Winthrop KL. Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin Chest Med. 2015;36(1):91–9.

    Article  Google Scholar 

  8. Lau CH, Missotten T, Salzmann J, Lightman SL. Acute retinal necrosis features, management, and outcomes. Ophthalmology. 2007;114(4):756–62.

    Article  Google Scholar 

  9. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):e44–100.

    Article  Google Scholar 

  10. Fasanya AA, Pedersen FT, Alhassan S, Adjapong O, Thirumala R. Cytomegalovirus Cutaneous Infection in an Immunocompromised Patient. Cureus. 2016;8(5):e598.

    Google Scholar 

  11. Hall LD, Eminger LA, Hesterman KS, Heymann WR. Epstein–Barr virus: Dermatologic associations and implications: Part I. Mucocutaneous manifestations of Epstein–Barr virus and nonmalignant disorders. J Am Acad Dermatol. 2015;72(1):1–19.

    Article  Google Scholar 

  12. Brasileiro CB, Abreu M, Mesquita RA. Critical review of topical management of oral hairy leukoplakia. World J Clin Cases. 2014;2(7):253–6.

    Article  Google Scholar 

  13. Rouanet J, Aubin F, Gaboriaud P, Berthon P, Feltkamp MC, Bessenay L, et al. Trichodysplasia spinulosa: a polyomavirus infection specifically targeting follicular keratinocytes in immunocompromised patients. Br J Dermatol. 2016;174(3):629–32.

    Article  CAS  Google Scholar 

  14. Wanat KA, Holler PD, Dentchev T, Simbiri K, Robertson E, Seykora JT, et al. Viral-associated trichodysplasia: characterization of a novel polyomavirus infection with therapeutic insights. Arch Dermatol. 2012;148(2):219–23.

    Article  CAS  Google Scholar 

  15. Santesteban R, Feito M, Mayor A, Beato M, Ramos E, de Lucas R. Trichodysplasia Spinulosa in a 20-month-old girl with a good response to topical cidofovir 1%. Pediatrics. 2015;136(6):e1646–9.

    Article  Google Scholar 

  16. Aleissa M, Konstantinou MP, Samimi M, Lamant L, Gaboriaud P, Touze A, et al. Trichodysplasia spinulosa associated with HIV infection: clinical response to acitretin and valganciclovir. Clin Exp Dermatol. 2018;43(2):231–3.

    Article  CAS  Google Scholar 

  17. Mays SR, Bogle MA, Bodey GP. Cutaneous fungal infections in the oncology patient: recognition and management. Am J Clin Dermatol. 2006;7(1):31–43.

    Article  Google Scholar 

  18. Shields BE, Rosenbach M, Brown-Joel Z, Berger A, Ford BA, Wanat KA. Angioinvasive fungal infections impacting the skin: background, epidemiology, and clinical presentation (part 1). J Am Acad Dermatol. 2019;80(4):869–880.e5.

    Article  Google Scholar 

  19. Iwen PC, Rupp ME, Hinrichs SH. Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature. Clin Infect Dis. 1997;24(6):1178–84.

    Article  CAS  Google Scholar 

  20. Payne AS, James WD, Weiss RB. Dermatologic toxicity of chemotherapeutic agents. Semin Oncol. 2006;33(1):86–97.

    Article  CAS  Google Scholar 

  21. Reyes-Habito CM, Roh EK. Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs. J Am Acad Dermatol. 2014;71(2):203.e1–203.e12. quiz 15–6.

    Article  CAS  Google Scholar 

  22. Macdonald JB, Macdonald B, Golitz LE, LoRusso P, Sekulic A. Cutaneous adverse effects of targeted therapies: part I: inhibitors of the cellular membrane. J Am Acad Dermatol. 2015;72(2):203–18. quiz 19–20.

    Article  CAS  Google Scholar 

  23. McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochimica et Biophysica Acta. 2008;1782(3):127–50.

    Article  CAS  Google Scholar 

  24. Scarisbrick JJ, Child FJ, Evans AV, Fraser-Andrews EA, Spittle M, Russell-Jones R. Secondary malignant neoplasms in 71 patients with sézary syndrome. Arch Dermatol. 1999;135(11):1381–5.

    Article  CAS  Google Scholar 

  25. Kaplan AL, Cook JL. Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. Skinmed. 2005;4(5):300–4.

    Article  Google Scholar 

  26. DePry JL, Vyas R, Lazarus HM, Caimi PF, Gerstenblith MR, Bordeaux JS. Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review. JAMA Dermatol. 2015;151(7):775–82.

    Article  Google Scholar 

  27. Cheng JY, Li FY, Ko CJ, Colegio OR. Cutaneous squamous cell carcinomas in solid organ transplant recipients compared with immunocompetent patients. JAMA Dermatol. 2018;154(1):60–6.

    Article  CAS  Google Scholar 

  28. Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous Belmonte S, et al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst. 2016;108(6):djv403.

    Article  CAS  Google Scholar 

  29. Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management. Am J Hematol. 2018;93(7):953–62.

    Article  CAS  Google Scholar 

  30. Hristov AC. Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations. Arch Pathol Lab Med. 2012;136(8):876–81.

    Article  Google Scholar 

  31. Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, et al. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol. 2010;84(14):7064–72.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oregon Health & Science University, Department of Dermatology, Portland, OR, USA

    Jina Chung

  2. Medical College of Wisconsin, Department of Dermatology, Milwaukee, WI, USA

    Karolyn A. Wanat

Authors
  1. Jina Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karolyn A. Wanat
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Dermatology, University of Iowa Health Care, Iowa, IA, USA

    Vincent Liu

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chung, J., Wanat, K.A. (2021). Infection, Skin, and Systemic Malignancy. In: Liu, V. (eds) Dermato-Oncology Study Guide. Springer, Cham. https://doi.org/10.1007/978-3-030-53437-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-53437-0_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-53436-3

  • Online ISBN: 978-3-030-53437-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation